Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew H Porteus

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2015
Genome editing technologies: defining a path to clinicJacqueline Corrigan-Curay, Marina O'Reilly, Donald B Kohn, et al.
Science (New York, N.Y.)|October 12, 2013
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin levelDaniel E Bauer, Sophia C Kamran, Samuel Lessard, et al.
Cancer Research|June 28, 2022
Reengineering Ponatinib to Minimize Cardiovascular ToxicityAnna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor, et al.
Science (New York, N.Y.)|March 5, 2016
Activation of proto-oncogenes by disruption of chromosome neighborhoodsDenes Hnisz, Abraham S Weintraub, Daniel S Day, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Durable reconstitution of sinonasal epithelium by transplant of CFTR gene corrected airway stem cellsDawn T Bravo, Sriram Vaidyanathan, Jeannette Baker, et al.
Science (New York, N.Y.)|October 27, 2018
Protect NIH's DNA advisory committeeZach N Adelman, Lorraine M Albritton, Kathleen Boris-Lawrie, et al.
Cell Stem Cell|May 4, 2019
Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous RecombinationRenata M Martin, Kazuya Ikeda, M Kyle Cromer, et al.
Nature Medicine|January 30, 2019
Identification of preexisting adaptive immunity to Cas9 proteins in humansCarsten T Charlesworth, Priyanka S Deshpande, Daniel P Dever, et al.
Frontiers in Immunology|January 23, 2023
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cellsJulie Brault, Taylor Liu, Siyuan Liu, et al.
Nature Medicine|August 8, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cellsChristopher A Vakulskas, Daniel P Dever, Garrett R Rettig, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 7, 2015
Genome editing technologies: defining a path to clinicJacqueline Corrigan-Curay, Marina O'Reilly, Donald B Kohn, et al.
Science (New York, N.Y.)|October 12, 2013
An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin levelDaniel E Bauer, Sophia C Kamran, Samuel Lessard, et al.
Cancer Research|June 28, 2022
Reengineering Ponatinib to Minimize Cardiovascular ToxicityAnna P Hnatiuk, Arne A N Bruyneel, Dhanir Tailor, et al.
Science (New York, N.Y.)|March 5, 2016
Activation of proto-oncogenes by disruption of chromosome neighborhoodsDenes Hnisz, Abraham S Weintraub, Daniel S Day, et al.
Biorxiv : the Preprint Server for Biology|February 3, 2025
Durable reconstitution of sinonasal epithelium by transplant of CFTR gene corrected airway stem cellsDawn T Bravo, Sriram Vaidyanathan, Jeannette Baker, et al.
Science (New York, N.Y.)|October 27, 2018
Protect NIH's DNA advisory committeeZach N Adelman, Lorraine M Albritton, Kathleen Boris-Lawrie, et al.
Cell Stem Cell|May 4, 2019
Highly Efficient and Marker-free Genome Editing of Human Pluripotent Stem Cells by CRISPR-Cas9 RNP and AAV6 Donor-Mediated Homologous RecombinationRenata M Martin, Kazuya Ikeda, M Kyle Cromer, et al.
Nature Medicine|January 30, 2019
Identification of preexisting adaptive immunity to Cas9 proteins in humansCarsten T Charlesworth, Priyanka S Deshpande, Daniel P Dever, et al.
Frontiers in Immunology|January 23, 2023
CRISPR-Cas9-AAV versus lentivector transduction for genome modification of X-linked severe combined immunodeficiency hematopoietic stem cellsJulie Brault, Taylor Liu, Siyuan Liu, et al.
Nature Medicine|August 8, 2018
A high-fidelity Cas9 mutant delivered as a ribonucleoprotein complex enables efficient gene editing in human hematopoietic stem and progenitor cellsChristopher A Vakulskas, Daniel P Dever, Garrett R Rettig, et al.
Pageof 15